Table 1.
Indication for scan* | 2008–2009 | 2018–2019 | ||
---|---|---|---|---|
Age < 70** | Age ≥ 70*** | Age < 70** | Age ≥70*** | |
Headache, n (%) | 7 (13.2) | 3 (3.9) | 4 (9) | 2 (1.7) |
Cerebrovascular incident, n (%) | 3 (5.7) | 25 (32.9) | 5 (11.1) | 23 (19.8) |
Head injury, n (%) | 13 (24.5) | 14 (18.4) | 10 (22.2) | 30 (26) |
Audiovestibular symptoms, n (%) | 1 (1.9) | 1 (1.3) | 0 (0) | 1 (0.9) |
Visual symptoms, n (%) | 1 (1.9) | 2 (2.6) | 5 (11.1) | 2 (1.7) |
Psychiatric symptoms, n (%) | 3 (5.7) | 2 (2.6) | 1 (2.2) | 3 (2.6) |
Cognitive symptoms, n (%) | 0 (0) | 9 (11.8) | 1 (2.2) | 14 (12.1) |
Loss of consciousness, n (%) | 1 (1.9) | 4 (5.2) | 0 (0) | 7 (6) |
Vertigo, n (%) | 7 (13.6) | 10 (13.1) | 2 (4.4) | 7 (6) |
Lethargy, n (%) | 1 (1.9) | 2 (2.6) | 1 (2.2) | 5 (4.3) |
Scan for metastases, n (%) | 4 (7.5) | 0 (0) | 4 (9) | 12 (10.3) |
Other ****, n (%) | 12 (22.6) | 4 (5.2) | 12 (26.6) | 10 (8.6) |
*Symptoms deemed not associated with the meningioma in question
** p = 0.5
*** p = 0.046
**** Data on “other” available in Supplementary Table 1